BTN3A2 encodes a member of the immunoglobulin superfamily and is involved in the T cell-mediated immune responses; as such, it is considered a possible factor associated with favorable prognosis in ovarian cancer patients37, 38. Here, BTN3A2 is linked to ovarian carcinoma.